Market Cap 682.11M
Revenue (ttm) 57.56M
Net Income (ttm) -44.14M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -76.69%
Debt to Equity Ratio -0.44
Volume 2,019,484
Avg Vol 3,213,316
Day's Range N/A - N/A
Shares Out 99.72M
Stochastic %K 32%
Beta 1.77
Analysts Strong Sell
Price Target $9.07

Company Profile

Aquestive Therapeutics, Inc. operates as a pharmaceutical company in the United States and internationally. It offers Libervant, a buccal soluble film formulation of diazepam for the treatment of seizures; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; KYNMOBI a sublingual film formulation of apomorphine for the treatment of episodic...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 908 941 1900
Address:
30 Technology Drive, Warren, United States
drose0527
drose0527 Oct. 27 at 8:59 PM
$AQST love the fact this has touched or closed no lower than 6.82-6.84. Showing a very strong floor build here the last 4 trading sessions. It’s only a matter of days before we make a run back towards 8 if not higher! Cooling the RSI helps and who knows maybe 6.82 is the new .66 cents floor and this baby runs to 68 upon approval. I mean considering that was 10 x .66 puts us at 6.60 who’s to say 6.80 x 10 can’t put us at 68
0 · Reply
Oliver17
Oliver17 Oct. 27 at 8:43 PM
$AQST Question out there to anyone?? What do you all think of the short % rising? Cramer's following shorting or more institutional digging their heels in the sand?
1 · Reply
LiquidThetaOptions
LiquidThetaOptions Oct. 27 at 8:18 PM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $AQST Current Share Price: $6.96 Contracts: $AQST May 15, 2026 $7 Calls Scale in: $1.97- $2.41 Scale out: $3.07-$3.94 Can Easily Capture: 60% ROI Blended DTE: 200 Days | Join Elites here: https://liquidtheta.com
0 · Reply
ConfidencePotato
ConfidencePotato Oct. 27 at 7:50 PM
$AQST $KURA 7 eleven 😉
0 · Reply
BigGainTom
BigGainTom Oct. 27 at 6:30 PM
$AQST close around 7.10 to complete the 5 day cup and handle.
0 · Reply
Rock6Times
Rock6Times Oct. 27 at 5:41 PM
$AQST very atrong pipeline = biyout bait.
0 · Reply
Acemaker12
Acemaker12 Oct. 27 at 5:09 PM
$AQST Link to epinephrine 101 talk: https://www.buzzsprout.com/848314/episodes/18019217
0 · Reply
Stone52
Stone52 Oct. 27 at 4:20 PM
$AQST $SPRY $NVS $RNA M&A in the biotech space continues to heat up as Novartis is buying U.S. biotech firm Avidity Biosciences for about $12 billion in cash - announced this morning. Neither AQST or SPRY will be stand-alone companies at some point.
1 · Reply
UnderLion16
UnderLion16 Oct. 27 at 4:19 PM
$AQST https://www.linkedin.com/posts/faact-food-allergy-%26-anaphylaxis-connection-team_sponsored-faactsroundtable-podcast-activity-7388545270264885249-9v4R?utm_source=share&utm_medium=member_desktop&rcm=ACoAAEsd0XQB-kbKVWH1Winw4qDcCWoIeyftplo
0 · Reply
NCpilot172
NCpilot172 Oct. 27 at 4:08 PM
$AQST Could see a correction on er, especially with all the Cramer followers. Expecting a disappointment in all honesty. Doesn’t take much when you see people coming in here with “what does the clinical data look like? I didn’t even check before I bought” why would anyone buy a stock like this without even knowing what the clinical data for the main value driver (as of right now) looks like?
0 · Reply
Latest News on AQST
Aquestive Therapeutics: A Measured Bet

Oct 12, 2025, 2:57 AM EDT - 15 days ago

Aquestive Therapeutics: A Measured Bet


Aquestive Therapeutics Broadens Patent Estate for Anaphylm™

Oct 8, 2025, 7:00 AM EDT - 19 days ago

Aquestive Therapeutics Broadens Patent Estate for Anaphylm™


Aquestive Therapeutics: Five Foci For 2025

Jan 6, 2025, 12:13 AM EST - 10 months ago

Aquestive Therapeutics: Five Foci For 2025


Aquestive: Rare Opportunity With Dual Platform Strategy

Nov 5, 2024, 2:09 PM EST - 1 year ago

Aquestive: Rare Opportunity With Dual Platform Strategy


Aquestive Therapeutics: Bullish Roadmap After Q2 Earnings

Aug 22, 2024, 11:37 PM EDT - 1 year ago

Aquestive Therapeutics: Bullish Roadmap After Q2 Earnings


drose0527
drose0527 Oct. 27 at 8:59 PM
$AQST love the fact this has touched or closed no lower than 6.82-6.84. Showing a very strong floor build here the last 4 trading sessions. It’s only a matter of days before we make a run back towards 8 if not higher! Cooling the RSI helps and who knows maybe 6.82 is the new .66 cents floor and this baby runs to 68 upon approval. I mean considering that was 10 x .66 puts us at 6.60 who’s to say 6.80 x 10 can’t put us at 68
0 · Reply
Oliver17
Oliver17 Oct. 27 at 8:43 PM
$AQST Question out there to anyone?? What do you all think of the short % rising? Cramer's following shorting or more institutional digging their heels in the sand?
1 · Reply
LiquidThetaOptions
LiquidThetaOptions Oct. 27 at 8:18 PM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $AQST Current Share Price: $6.96 Contracts: $AQST May 15, 2026 $7 Calls Scale in: $1.97- $2.41 Scale out: $3.07-$3.94 Can Easily Capture: 60% ROI Blended DTE: 200 Days | Join Elites here: https://liquidtheta.com
0 · Reply
ConfidencePotato
ConfidencePotato Oct. 27 at 7:50 PM
$AQST $KURA 7 eleven 😉
0 · Reply
BigGainTom
BigGainTom Oct. 27 at 6:30 PM
$AQST close around 7.10 to complete the 5 day cup and handle.
0 · Reply
Rock6Times
Rock6Times Oct. 27 at 5:41 PM
$AQST very atrong pipeline = biyout bait.
0 · Reply
Acemaker12
Acemaker12 Oct. 27 at 5:09 PM
$AQST Link to epinephrine 101 talk: https://www.buzzsprout.com/848314/episodes/18019217
0 · Reply
Stone52
Stone52 Oct. 27 at 4:20 PM
$AQST $SPRY $NVS $RNA M&A in the biotech space continues to heat up as Novartis is buying U.S. biotech firm Avidity Biosciences for about $12 billion in cash - announced this morning. Neither AQST or SPRY will be stand-alone companies at some point.
1 · Reply
UnderLion16
UnderLion16 Oct. 27 at 4:19 PM
$AQST https://www.linkedin.com/posts/faact-food-allergy-%26-anaphylaxis-connection-team_sponsored-faactsroundtable-podcast-activity-7388545270264885249-9v4R?utm_source=share&utm_medium=member_desktop&rcm=ACoAAEsd0XQB-kbKVWH1Winw4qDcCWoIeyftplo
0 · Reply
NCpilot172
NCpilot172 Oct. 27 at 4:08 PM
$AQST Could see a correction on er, especially with all the Cramer followers. Expecting a disappointment in all honesty. Doesn’t take much when you see people coming in here with “what does the clinical data look like? I didn’t even check before I bought” why would anyone buy a stock like this without even knowing what the clinical data for the main value driver (as of right now) looks like?
0 · Reply
Ravery
Ravery Oct. 27 at 3:44 PM
$AQST Shorts digging their heels in. SI hit a new 52 week high @ 12.25 M shares as of 10/15. It was 8.88M a month earlier. The Cramer pump was not short covering.
1 · Reply
1ightningscalps
1ightningscalps Oct. 27 at 3:01 PM
1ightning® Options Trade Alert (Actionable) | Buy $AQST Nov 21 $8 Call | Enter: $0.60 Exit: $1.00 | Profit: 66.74% ROI | https://1ightning.com
0 · Reply
Acemaker12
Acemaker12 Oct. 27 at 2:24 PM
0 · Reply
TIG2
TIG2 Oct. 27 at 1:59 PM
$AQST Would a out of US partner affect our buy-out prospects ? Maybe that's why nothing yet...
1 · Reply
UnderLion16
UnderLion16 Oct. 27 at 1:24 PM
$AQST https://investors.aquestive.com/news-releases/news-release-details/aquestive-therapeutics-report-third-quarter-2025-financial
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 27 at 5:38 AM
Enter: $AQST Calls Strike Price: $8 Expiry Date: NOV 21 2025 Buy in Price: $0.60 - $0.75 Sell Price: $0.89 Profit : +48% (Turn every $1 into $1.48) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us/
0 · Reply
Dp2424
Dp2424 Oct. 27 at 3:51 AM
$AQST How are we doing folks? $7.50+ tomorrow?
2 · Reply
Biotechnicity
Biotechnicity Oct. 26 at 3:47 PM
$AQST https://youtu.be/d5LiDs8mKig?si=edJNjs1ETxbPXnM9 Of course we all feel it to varying degrees. Some of us have known this for years and been derided by the intelligences remnant on stock message boards. Which is to say, by fookinitliots. See how easy it would be, is, to manipulate the market? It’s done for the hedge funds with short positions locked onto the preselected run-up (Cramer?) price. As trader’s know, the real money is in buying and selling puts. It isn’t to say that Cramer is making a bad pick here. Hopefully, he isn’t! It is to say he makes the wealthy wealthier, the rich richier and so on by providing the necessary cover. Beautiful day today.
1 · Reply
LiquidThetaOptions
LiquidThetaOptions Oct. 26 at 1:14 PM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $AQST Current Share Price: $6.84 Contracts: $AQST May 15, 2026 $7 Calls Scale in: $2.02- $2.47 Scale out: $3.14-$4.04 Can Easily Capture: 60% ROI Blended DTE: 201 Days | Join Elites here: https://liquidtheta.com
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 26 at 9:47 AM
Enter: $AQST Calls Strike Price: $8 Expiry Date: NOV 21 2025 Buy in Price: $0.60 - $0.75 Sell Price: $0.89 Profit : +48% (Turn every $1 into $1.48) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us/
0 · Reply
tedevan
tedevan Oct. 25 at 9:33 PM
0 · Reply
drose0527
drose0527 Oct. 25 at 5:04 PM
$AQST looks like it’s trying to make a run. Even though we are closing in the red we are still having an underlying conviction of buying which tells me that while heads are exchanged we will break to the upper side again and run into the 8’s or maybe even 9 in November. If you do factor in inflation. Again 5 years ago we went from 7-9 in the course of 3 month of Oct-Dec. I think we will make the same move but with bigger up side so we may go 7-9-11 the next three months. Either way we are in count down mode. Stock looks to be very stable in the 6.70 range for a new ground floor. Accumulation seems like it’s still happening just a matter of waiting it out. But I think we could see a move north of 8 in the next 1-2 weeks as November comes crawling in
1 · Reply